Permanent impairment of insulin resistance from pregnancy to adulthood: The primary basic risk factor of chronic Western diseases

Medical Hypotheses

Volumn 73, Issue 5, 2009, Pages 670-681

  Melnik, Bodo C ^a  

^a UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONTRACEPTIVE AGENT; EPIGALLOCATECHIN GALLATE; GLUCOCORTICOID; INSULIN; METFORMIN; NICOTINIC ACID; SOMATOMEDIN C; THIAZIDE DIURETIC AGENT;

ADOLESCENCE; ADULTHOOD; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC DISEASE; DAIRY PRODUCT; DIABETES MELLITUS; DRUG MECHANISM; DYSLIPIDEMIA; FOOD INTAKE; GLUCOSE TOLERANCE; HUMAN; INFANCY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; MILK; MUSCLE ATROPHY; NONHUMAN; OBESITY; OVERNUTRITION; PATHOPHYSIOLOGY; PERINATAL PERIOD; PHYSICAL ACTIVITY; PREGNANCY; PRIORITY JOURNAL; PUBERTY; RISK FACTOR; SENESCENCE; SIGNAL TRANSDUCTION; SMOKING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN; INSULIN RESISTANCE; MODELS, THEORETICAL; PREGNANCY; RISK FACTORS; SIGNAL TRANSDUCTION; SOMATOMEDINS;

MAMMALIA;

EID: 70349739304     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.04.047     Document Type: Article

References (194)

1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Flores-Riveros J.R., McLenithan J.C., Ezaki O., and Lane M.D. Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover. Proc Natl Acad Sci 90 (1993) 512-516
3. Brismar K., Fernqvist-Forbes E., Wahren J., and Hall K. Effect of insulin on the hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 79 (1994) 872-878
4. Bramnert M., Segerlantz M., Laurila E., Daugaard J.R., Manhem P., and Groop L. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. J Clin Endocrinol Metab 88 (2003) 1455-1463
5. Denley A., Cosgrove L.J., Booker G.W., Wallace J.C., and Forbes B.E. Molecular interactions of the IGF system. Cytokine Growth Factor Rev 16 (2005) 421-439
6. Denley A., Wallace J.C., Cosgrove L.J., and Forbes B.E. The insulin receptor isoform exon 11-(IR-A) in cancer and other diseases: a review. Horm Metab Res 35 (2003) 778-785
7. Le Roith D. Insulin-like growth factors. N Engl J Med 336 (1997) 633-640
8. Resnicoff M., and Basega R. The role of insulin-like growth factor I receptor in transformation and apoptosis. Ann NY Acad Sci 842 (1998) 76-81
9. Fürstenberger G., and Senn H.-J. Insulin-like growth factors and cancer. Lancet 3 (2002) 298-302
10. Caufriez A., Frankenne F., Hennen G., and Copinschi G. Regulation of maternal IGF-I by placental GH in normal and abnormal pregnancies. Am J Physiol 265 (1993) E572-E577
11. Chellakooty M., Vangsgaard K., Larsen T., Scheike T., Falck-Larsen J., Legarth J., et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: Association between placental GH and fetal growth. J Clin Endocrinol Metab 89 (2004) 384-391
12. Catalano P.M., Huston L., Amini S.B., and Kalhan S.C. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180 (1999) 903-916
13. Yamashita H., Shao J., and Friedman J.E. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes. Clin Obstet Gynecol 43 (2000) 87-98
14. Barbour L.A., Shao J., Qiao L., Pulawa L.K., Jensen D.R., Bartke A., et al. Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol 186 (2002) 512-517
15. Barbour L.A., Shao J., Qiao L., Leitner W., Anderson M., Friedman J.E., et al. Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Endocriology 145 (2004) 1144-1150
16. Illsley N.P. Glucose transporters in the human placenta. Placenta 21 (2000) 14-22
17. Ogilvy-Stuart A.L., Hands S.J., Adcock C.J., Holly J.M., Matthews D.R., Mohamed-Ali V., et al. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab 83 (1998) 3550-3557
18. Sferruzzi-Perri A.N., Owens J.A., Standen P., Taylor R.L., Robinson J.S., and Roberts C.T. Early pregnancy maternal endocrine insulin-like growth factor I programs the placenta for increased functional capacity throughout gestation. Endocrinology 148 (2007) 4362-4370
19. Gicquel C., and Le Bouc Y. Hormonal regulation of fetal growth. Horm Res 65 Suppl. 3 (2006) 28-33
20. Larnkjaer A., Ingstrup H.K., Schack-Nielsen L., Hoppe C., Molgaard C., Skovgaard I.M., et al. Early programming of the IGF-I axis: Negative association between IGF-I in infancy and late adolescence in a 17-year longitudinal follow-up study of healthy subjects. Growth Horm IGF Res 19 (2009) 82-86
21. Fowden A.L. The role of insulin in prenatal growth. J Dev Physiol 12 (1989) 173-182
22. Economides D.L., and Nicolaides K.H. Metabolic findings in small-for-gestational-age fetuses. Contemp Rev Obstet Gynaecol 2 (1990) 75-79
23. Yang S.W., and Yu J.S. Relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, growth hormone in cord blood and maternal factors with birth height and birthweight. Pediatr Internat 42 (2000) 31-36
24. Kaplan S.L., Grumbach M.M., and Shephard T.H. The ontogenesis of human fetal hormones. I. Growth hormone and insulin. J Clin Invest 51 (1972) 3080-3093
25. Cornblath M., Parker M.L., Reisner S.H., Forbes A.E., and Daughaday W.H. Secretion and metabolism of growth hormone in premature and full-term infants. J Clin Endocrinol 25 (1965) 209-218
26. Aynsley-Green A., Bloom S.R., Williamson D.H., and Turner R.C. Endocrine and metabolic response in the human newborn to first feed of breast milk. Arch Dis Child 52 (1977) 291-295
27. Gluckman P.D., Grumbach M.M., and Kaplan S.L. The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus. Endocr Rev 2 (1977) 363-395
28. Adrian T.E., Lucas A., Bloom S.R., and Aynsley-Green A. Growth hormone response to feeding in term and preterm neonates. Acta Paediatr Scand 72 (1983) 251-254
29. Quattrin T., Albini C.H., Cara J.F., Vandlen R.L., Mills B.J., and MacGillivray M.H. Quantitation of urinary somatomedin-C and growth hormone in preterm and fullterm infants and normal children. J Clin Endocrinol Metab 66 (1988) 792-797
30. Deiber M., Chatelain P., Naville D., Putet G., and Salle B. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. J Clin Endocrinol Metab 68 (1989) 232-234
31. Miller J.D., Wright N., Esparza A., Jansons R., Yang H.C., and Mosier H.D. Spontaneous growth hormone release in male and female premature infants. J Clin Endocrinol Metab 75 (1992) 1508-1513
32. Bang P., Westgren M., Schwander J., Blum W.F., Rosenfeld R.G., and Stangenberg M. Ontogeny of insulin-like growth factor binding protein-1, -2, and -3: quantitative measurements by radioimmunoassays in human fetal serum. Pedriatr Res 36 (1994) 528-536
33. Hasegawa Y., Hasegawa T., Fujii K., Konii H., Anzo M., Aso T., et al. High ratios of free to total insulin-like growth factor-I in early infancy. J Clin Endocrinol Metab 82 (1997) 156-158
34. Belgorosky A., Baquedano M.S., Guerico G., and Rivarola M.A. Adrenarche: postnatal adrenal zonation and hormonal and metabolic regulation. Horm Res 70 (2008) 257-267
35. Guerico G., Rivarola M.A., Chaler E., Maceiras M., and Belgorosky A. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab 88 (2003) 1389-1393
36. Giovannucci E., Pollak M., Liu Y., Platz E.A., Majeed N., Rimm E.B., et al. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in man. Cancer Epidemiol Biomarkers Prev 12 (2003) 84-89
37. Holmes M.D., Pollak M.N., Willett W.C., and Hankinson S.E. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11 (2002) 852-861
38. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17 (2006) 4-12
39. Falorni A., Bini V., Cabiati G., Papi F., Arzano S., Celi F., et al. Serum levels of type I procollagen C-terminal peptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status. Metabolism 46 (1997) 862-871
40. Chan J.M., Stampfer M.J., Giovannucci E., Gann P.H., Ma J., Wilkinson P., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 (1998) 563-566
41. Boyd D.B. Insulin and cancer. Integr Cancer Ther 2 (2003) 315-329
42. Clemmons D.R. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nature Rev 6 (2007) 821-833
43. Cohen E., and Dillin A. The insulin paradox: aging, proteotoxicity and neurodegeneration. Nature Rev Neurosci 9 (2008) 759-767
44. Taguchi A., and White M.F. Insulin-like signaling, nutrient homeostasis, and life span. Ann Rev Physiol 70 (2008) 191-212
45. Gluckman P.D., and Hanson M.A. The developmental origins of the metabolic syndrome. Trends Endocrinol Metab 15 (2004) 183-187
46. Bateson P., Barker D., Clutton-Brock T., Deb D., D'Udine B., Foley R.A., et al. Developmental plasticity and human health. Nature 430 (2004) 419-421
47. McMillen, and Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85 (2005) 571-633
48. Hales C.N., and Barker D.J. The thrifty phenotype hypothesis. Br Med Bull 60 (2001) 5-20
49. Leon D.A. Fetal growth and adult disease. Eur J Clin Nutr 52 Suppl. 1 (1998) S72-S78 [discussion S78-2]
50. Ibánez L., Potau N., Francois I., and de Zegher F. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83 (1998) 3558-3562
51. Du J., Peng T., Scheidegger K.J., and Delafontaine P. Angiotensin II activation of insulin-like growth factor 1 receptor transcription is mediated by a tyrosine kinase-dependent redox sensitive mechanism. Arterioscler Thromb Vasc Biol 19 (1999) 2119-2126
52. Brink M., Chrast J., Price S.R., Mitch W.E., and Delafontaine D. Angiotensin II stimulated gene expression of cardiac insulin-like growth factor I and its receptor through effects on blood pressure and food intake. Hypertension 34 (1999) 1053-1059
53. Andronico G., Mangano M.T., Ferrara L., Lamanna D., Mulè G., and Cerasola G. Insulin-like growth factor 1 and pressure load in hypertensive patients. Am J Hypertens 9 (1996) 607-609
54. Barker D.J., Osmond C., Golding J., Kuh D., and Wadsworth M.E. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298 (1989) 564-567
55. Gicquel C., El-Osta A., and le Bouc Y. Epigenetic regulation and fetal programming. Best Prac Res Clin Endocrinol Metab 22 (2008) 1-16
56. Gluckman P.D., and Hanson M.A. Living with the past: evolution, development, and patterns of disease. Science 305 (2004) 1733-1736
57. Gluckman P.D., Hanson M.A., and Beedle A.S. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol 19 (2007) 1-19
58. Jaquet D., Collin D., Levy-Marchal C., and Czernichow P. Adult height distribution in subjects born small for gestational age. Horm Res 62 (2004) 92-96
59. Karlberg J.P., Albertsson-Wikland K., Kwan E.Y., Lam B.C., and Low L.C. The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age. Horm Res 48 Suppl. 1 (1997) 17-24
60. Huizinga C.T., Oudejans C.B., Steiner R.A., Clifton D.K., and Delemarre-van de Waal H.A. Effects of intrauterine and early postnatal growth restriction on hypothalamic somatostatin gene expression in the rat. Pediatr Res 48 (2000) 815-820
61. Woodall S.M., Breier B.H., Johnston B.M., and Gluckman P.D. A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: effects on the somatotrophic axis and postnatal growth. J Endocrinol 150 (1996) 231-242
62. Chiesa C., Osborn J.F., Haass C., Natale F., Spinelli M., Scapillati E., et al. Ghrelin, leptin, IGF-1, IGFBP-3, and insulin concentrations at birth: is there a relationship with fetal growth and neonatal anthropometry. Clin Chem 3 (2008) 550-558
63. Kappeler L., De Magalhaes Filho C., Leneuve P., Xu J., Brunel N., Chattziantoniou C., et al. Early postnatal nutrition determines somatotropic function in mice. Endocrinology 150 (2009) 314-323
64. Cheung N.W. The management of gestational diabetes. Vasc Health Risk Manag 5 (2009) 153-164
65. Hillier T.A., Pedula K.L., Vesco K.K., Schmidt M.M., Mullen J.A., LeBlanc E.S., et al. Excess gestational weight gain: modifying fetal macrosomia risk associated with maternal glucose. Obstet Gynecol 112 (2008) 1007-1014
66. Koklu E., Kurtoglu S., Akcakus M., Yikilmaz A., and Gunes T. Serum insulin-like growth factor-I (IGF-I) IGF binding protein-3 (IGFBP-3) and leptin levels are related to abdominal aortic intima-media thickness in macrosomic newborns. Growth Horm IGF Res 17 (2007) 26-32
67. Akcakus M., Koklu E., Kurtoglu S., Kula M., and Koklu S.S. The relationship among intrauterine growth, insulin-like growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants. Am J Perinatol 23 (2006) 473-480
68. Lo H.C., Tsao L.Y., Hsu W.Y., Chen H.N., Yu W.K., and Chi C.Y. Relation of cord serum levels of growth hormone, insulin-like growth factors, insulin-like growth factor binding proteins, leptin, and interleukin-6 with birth weight, birth length, and head circumference in term and preterm neonates. Nutrition 18 (2002) 604-608
69. Ong K.K., Diderholm B., Salzano G., Wingate D., Hughes I.A., MacDougall J., et al. Pregnancy insulin, glucose, and BMI contribute to birth outcomes in nondiabetic mothers. Diabetes Care 31 (2008) 2193-2197
70. Bramnert M, Berntorp E, Groop L, Manhem P. Effects of growth hormone replacement therapy on cardiovascular risk factors in patients with GHD. In: Program of the 77th annual meeting of the American Endocrine Society, Washington DC, 1995 [abstract P2 273].
71. Johnston D.G., Al-Shoumer K.A., Chrisoulidou A., Kousta E., Beshyah S., and Robinson S. Long term effects of growth hormone therapy on intermediary metabolism and insulin sensitivity in hypopituitary adults. J Endocrinol Invest 22 Suppl. 5 (1999) 37-40
72. Blum J.W., and Baumrucker C.R. Insulin-like growth factors (IGFs), IGF binding proteins, and other endocrine factors in milk: role in the newborn. In: Bösze Z. (Ed). Bioactive components of milk. Advances in experimental medicine and biology vol. 606 (2008), Springer, New York 397-422
73. Collier R.J., Miller M.A., McLaughlin C.L., Johnson H.D., and Baile C.A. Effects of recombinant somatotropin (rbST) and season on plasma and milk insulin-like growth factors I (IGF-I) and II (IGF-II) in lactating dairy cows. Domestic Animal Endocrinol 35 (2008) 16-23
74. Collier R.J., Miller M.A., Hildebrandt J.R., Torkelson A.R., White T.C., Madsen K.S., et al. Factors affecting insulin-like growth factor-I concentration in bovine milk. J Dairy Sci 74 (1991) 2905-2911
75. Francis G.L., Upton F.M., Ballard F.J., McNeil K.A., and Wallace J.C. Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form. Biochem J 251 (1988) 95-103
76. Cadogan J., Eastell R., Jones N., and Barker M.E. Milk intake and bone mineral acquisition in adolescent girls. A randomised, controlled intervention trial. Br Med J 315 (1997) 1255-1260
77. Ma J., Giovannucci E., Pollak M., Chan J.M., Gaziano J.M., Willett W., et al. Milk-intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in man. J Natl Cancer Inst 93 (2001) 1330-1336
78. Hoppe C., Udam T.R., Lauritzen L., Molgaard C., Juul A., and Michaelsen K.F. Animal protein intake, serum insulin-like growth factor I, and growth in healthy 2.5-y-old Danish children. Am J Clin Nutr 80 (2004) 447-452
79. Hoppe C., Molgaard C., Vaag A., Barkholt V., and Michaelsen K.F. High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr 59 (2005) 393-398
80. Hoppe C., Molgaard C., Juul A., and Michaelsen K.F. High intakes of skimmed milk, but not meat increase serum IGF-I and IGFBP-3 in eight-year-old boys. Eur J Clin Nutr 58 (2004) 1211-1216
81. Rogers I.S., Gunnell D., Emmett P.M., Glynn L.R., Dunger D.B., and Holly J.M. Cross-sectional associations of diet and insulin-like growth factor levels in 7- to 8-year-old children. Cancer Epidemiol Biomarkers Prev 14 (2005) 204-212
82. Heaney R.P., McCarron D.A., Dawson-Hughes B., Oparil S., Berga S.L., Stern J.S., et al. Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assoc 99 (1999) 1228-1233
83. Esterle L., Sabatier J.P., Guillon-Metz F., Walrant-Debray O., Guaydier-Souquières G., Jehan F., et al. Milk, rather than other foods, is associated with vertebral bone mass and circulating IGF-1 in female adolescents. Osteoporos Int 20 (2009) 567-575
84. Norat T., Dossus L., Rinaldi S., Overvad K., Grønbaek H., Tjønneland A., et al. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 61 (2007) 91-98
85. Östman E.M., Liljeberg Elmstahl H.G.M., and Björck I.M.E. Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr 74 (2001) 96-100
86. Hoyt G., Hickey M.S., and Cordain L. Dissociation of the glycaemic and insulinaemic responses to whole and skimmed milk. Br J Nutr 93 (2005) 175-177
87. Gannon M.C., Nuttal F.Q., Krezowski P.A., Billington C.J., and Parker S. The serum insulin and plasma glucose responses to milk and fruit in type 2 (non-insulin-dependent) diabetic patients. Diabetologica 29 (1986) 784-791
88. Holt S., Brand Miller J., and Petocz P. An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr 66 (1997) 1264-1276
89. Hoppe C., Molgaard C., and Michaelsen K.F. Cow's milk and linear growth in industrialized and developing countries. Ann Rev Nutr 26 (2006) 131-173
90. Hoppe C, Molgaard C,Vaag A, Michaelsen KF. The effect of seven-day supplementation with milk protein fractions and milk minerals on IGFs and glucose-insulin metabolism in Danish pre-pubertal boys. Poster Presentation 2008; Department of Human Nutrition Faculty of Life Sciences, University of Copenhagen.
91. Larnkjær A., Hoppe C., Mølgaard C., and Michaelsen K.F. The effects of whole milk and infant formula on growth and IGF-I in late infancy. Eur J Clin Nutr (2009) [epub ahead of print]
92. Rich-Edwards J.W., Ganmaa D., Pollak M.N., Nakamoto E.K., Kleinman K., Tserendolgor U., Willett W.C., and Frazier A.L. Milk consumption and the prepubertal somatotropic axis. Nutr J 6 (2007) 28 10.1186/1475-2891-6-2
93. Ludwig D. The glycemic index: physiological mechanisms relating to obesity, diabetes and cardiovascular disease. JAMA 287 (2002) 2414-2423
94. Mannion C.A., Gray-Donald K., and Koski K.G. Association of low intake of milk and vitamin D during pregnancy with decreased birth weight. Can Med Assoc J 174 (2006) 1273-1277
95. Olsen S.F., Halldorsson T.I., Willett W.C., Knudsen V.K., Gillman M.W., Mikkelsen T.B., et al., NUTRIX Consortium. Milk consumption during pregnancy is associated with increased infant size at birth: prospective cohort study. Am J Clin Nutr 86 (2007) 1104-1110
96. Lucas A., Sarson D.L., Blackburn A.M., Adrain T.E., Aynsley-Green A., and Bloom S.R. Breast vs bottle: endocrine responses are different with formula feeding. Lancet 1 (1980) 1267-1269
97. Liljeberg E.H., and Bjorck I. Milk as a supplement to mixed meals may elevate postprandial insulinaemia. Eur J Clin Nutr 55 (2001) 994-999
98. Melnik B. Milk consumption: aggravating factor of acne and promoter of chronic diseases of Western societies. J Dtsch Dermatol Ges 7 (2009) 364-370
99. Cara J.F., Rosenfield R.L., and Furlanetto R.W. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child 141 (1987) 562-564
100. Aizawa H., and Niimura M. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol 22 (1995) 249-252
101. Cappel M., Mauger D., and Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 141 (2005) 333-338
102. Cordain L., Lindeberg S., Hurtado M., Hill K., Eaton S.B., and Brand-Miller J. Acne vulgaris. A disease of Western civilization. Arch Dermatol 138 (2002) 1584-1590
103. Adebamowo C.A., Spiegelman D., Berkey C.S., Danby F.W., Rockett H.H., Colditz G.A., et al. Milk consumption and acne in adolescent girls. Dermatol Online J 12 (2006) 1-12
104. Adebamowo C.A., Spiegelman D., Berkey C.S., Danby F.W., Rockett H.H., Colditz G.A., et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 58 (2008) 787-793
105. Rudman S.M., Philpott M.P., Thomas G.A., and Kealey T. The role of IGF-I in human skin and its appendages: morphogen as well as mitogen?. J Invest Dermatol 109 (1997) 770-777
106. Oakes S.R., Hynes K.M., Waters M.J., Herington A.C., and Werther G.A. Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J Clin Endorcrinol Metab 75 (1992) 1368-1373
107. Deplewski D., and Rosenfield R.L. Role of hormones in the pilosebaceous unit development. Endocrine Rev 21 (2000) 263-292
108. Vora S., Ovhal A., Jerajani H., Nair N., and Chakrabortty A. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol 159 (2008) 990-991
109. Downie M.M., Sanders D.A., and Kealey T. Modelling the remission of individual acne lesions in vitro. Br J Dermatol 147 (2002) 869-878
110. Smith T.M., Cong Z., Gilliland K.L., Clawson G.A., and Thiboutot D.M. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol 126 (2006) 1226-1232
111. Rosignoli C., Nicolas J.C., Jomard A., and Michel S. Involvement of the SREBP pathway in the mode of action of androgens in sebaceous glands in vivo. Exp Dermatol 12 (2003) 480-489
112. Eberle D., Hegarty B., Bossard P., Ferré P., and Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86 (2004) 839-848
113. Zouboulis C.C. The human skin as a hormone target and an endocrine gland. Hormones 3 (2004) 9-26
114. Makrantonaki E., Vogel K., Fimmel S., Oeff M., Seltmann H., and Zouboulis C.C. Interplay of IGF-1 and 17β-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol 43 (2008) 939-946
115. Berker B., Emral R., Demirel C., Corapcioglu D., Unlu C., and Kose K. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy. Gynecol Endocrinol 19 (2004) 125-133
116. Ibánez L., Ong K., Valls C., Marcos M.V., Dunger D.B., and de Zegher F. Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 91 (2006) 2888-2891
117. Wynn V., Adams P.W., Godsland I., Melrose J., Niththyananthan R., and Oakley N.W. Seed comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism. Lancet 1 (1979) 1045-1049
118. Godsland I.F., Crook D., Simpson R., Proudler T., Felton C., Lees B., et al. The effect of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 323 (1990) 1375-1381
119. Godsland I.F., Walton C., Felton C., Proudler A., Patel A., and Wynn V. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 74 (1992) 64-70
120. Meyer C., Talbot M., and Teede H. Effect of Implanon on insulin resistance in women with polycystic ovary syndrome. Au NZ J Obstet Gynaecol 45 (2005) 155-158
121. Cagnacci A., Ferrari S., Tirelli A., Zanin R., and Volpe A. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial. Contraception 79 (2009) 111-116
122. Danby F.W. Acne and milk, the diet myth, and beyond. J Am Acad Dermatol 52 (2005) 360-362
123. Danby F.W. Acne, dairy and cancer. Dermato-Endocrinol 1 (2009) 9-13
124. Ganmaa D., and Sato A. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Med Hypotheses 65 (2005) 1028-1037
125. Fritsche S., and Steinhart H. Occurrence of hormonally active compounds in food: a review. Eur Food Res Technol 209 (1999) 153-179
126. Soyal S., Ismail P.M., Li J., Mulac-Jericevic B., Conneely O.M., and Lydon J.P. Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res 4 (2002) 191-196
127. Ismail P.M., Amato P., Soyal S.M., DeMayo F.J., Conneely O.M., O'Malley B.W., et al. Progesteron involvement in the breast development and tumorigenesis - as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 68 (2003) 779-789
128. Melnik B., Jansen T., and Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges 5 (2007) 110-117
129. Melnik B.C. Androgen abuse in the community. Curr Opin Endocrinol Diabetes Obes 16 (2009) 218-223
130. Möhlig M., Jürgens A., Spranger J., Hoffmann K., Weickert M.O., Schlösser H.W., et al. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol 155 (2006) 127-130
131. Rodríguez-González G., Ramírez-Moreno R., Pérez P., Bilbao C., López-Ríos L., Díaz-Chico J.C., et al. The GGN and CAG repeat polymorphisms in the exon-1 of the androgen receptor gene are, respectively, associated with insulin resistance in men and with dyslipidemia in women. J Steroid Biochem Mol Biol 113 (2009) 202-208
132. Sawaya M.E., and Shalita A.R. Androgen receptor polymorphism (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J Cutan Med Surg 3 (1998) 9-15
133. Matilainen V., Koskela P., and Keinanen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet 356 (2000) 1165-1166
134. Hirsso P., Laakso M., Matilainen V., Hiltunen L., Rajala U., Jokelainen J., et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Centr Europ J Public Health 14 (2006) 78-81
135. Hirsso P., Rajala U., Laakso M., Hiltunen L., Harkonen P., and Keinanen-Kiukaanniemi S. Health-related quality of life and physical well-being among a 63-year-old cohort of women with androgenetic alopecia; a Finnish population-based study. Health Qual Life Outcomes 3 (2005) 49
136. Matilainen V.A., Makinen P.K., and Keinanen-Kiukaanniemi S.M. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study. J Cardiovasc Risk 8 (2001) 147-151
137. Ahouansou S., Le Toumelin P., Crickx B., and Descamps V. Association of androgenetic alopecia and hypertension. Euro J Dermatol 17 (2007) 220-222
138. Hirsso P., Rajala U., Hiltunen L., Jokelainen J., Keinanen-Kiukaanniemi S., and Nayha S. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology 214 (2007) 125-129
139. Reaven G., and Tsao P.S. Insulin resistance and compensatory hyperinsulinemia. The key player between cigarette smolking and cardiovascular diseases?. J Am Coll Cardiol 41 (2003) 1044-1047
140. Fagerberg B., Hulten L.M., and Hulthe J. Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study. Metabolism 52 (2003) 1460-1463
141. Bouros D., Tzouvelekis A., Anevlavis S., Doris M., Tryfon S., Froudarakis M., et al. Smoking acutely increases plasma ghrelin concentrations. Clin Chem 52 (2006) 777-778
142. Kojima M., Hosoda H., Date Y., Nakazoto M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 402 (1999) 656-660
143. Wilkins J.N., Carson H.E., Van Vunakis H., Hill M.A., Gritz E., and Jarvik M.E. Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacol (Berl) 78 (1982) 305-308
144. Stolzenberg-Solomon R.Z., Graubard B.I., Chari S., Limburg P., Taylor P.R., Virtamo J., et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294 (2005) 2872-2878
145. Kazakoff K., Cardesa T., Liu J., Adrian T.E., Bagchi D., Bagchi M., et al. Effect of voluntary physical exercise on high-fat diet-promoted pancreatic carcinogenesis in the hamster model. Nutr Cancer 26 (1996) 265-279
146. Limburg P.J., Stolzenberg-Solomon R.Z., Vierkant R.A., Roberts K., Sellers T.A., Taylor P.R., et al. Insulin, glucose, insulin resistance and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol 4 (2006) 1514-1521
147. Abbasi F., Farin H.M.F., Mamendola C., McGraw L., McLaughlin T., and Reaven G.M. Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers. Metab Clin Exp 57 (2008) 1108-1114
148. Cooper-DeHoff R.M., Pacanowski M.A., and Pepine C.J. Cardiovascular therapies and associated glucose homeostasis. J Am Coll Cardiol 53 Suppl. S (2009) S28-S34
149. Pollare T., Lithell H., Selinus I., and Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomized, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ 298 (1989) 1152-1157
150. Wicklmayr M., Rett K., Dietze M., and Mehnert H. Effects of beta-blocking agents on insulin secretion and glucose disposal. Horm Metab Res Suppl 22 (1990) 29-33
151. Jacob S., Rett K., and Henriksen E.J. Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?. Am J Hypertens 11 (1998) 1258-1265
152. van Raalte D.H., Ouwens D.M., and Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?. Eur J Clin Invest 39 (2009) 81-93
153. Prasad A., and Quyyumi A.A. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation 110 (2004) 1507-1512
154. Addison S., Stas S., Hayden M.R., and Sowers J.R. Insulin resistance and blood pressure. Curr Hypertens Rep 10 (2008) 319-325
155. Seely S. Diet and coronary disease: a survey of mortality rates and food consumption statistics of 24 countries. Med Hypotheses 7 (1981) 907-918
156. Michels K.B., Trichopoulos D., Robins J.M., Rosner B.A., Manson J.E., Hunter D.J., et al. Birthweight as a risk factor for breast cancer. Lancet 348 (1996) 1542-1546
157. Xue F., and Michels K.B. Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 8 (2007) 1088-1100
158. Schernhammer E.S. In-utero exposures and breast cancer risk: joint effects of estrogens and insulin-like growth factor?. Cancer Causes Control 13 (2002) 505-508
159. Geenen V. Thymus-dependent T cell tolerance of neuroendocrine functions. Principles, reflections, and implications for tolerogenic/negative self-vaccination. Ann NY Acad Sci 1088 (2006) 284-296
160. Kecha O., Brilot F., Martens H., Franchimont N., Renard C., Greimers R., et al. Involvement of insulin-like growth factors in early T-cell development: a study of using fetal thymic organ cultures. Endocrinology 141 (2000) 1209-1217
161. Ege M.J., Herzum I., Büchele G., Krauss-Etschmann S., Lauener R.P., et al., Protection Against Allergy Study in Rural Environments (PASTURE) Study group. Prenatal exposure to a farm environment modifies atopic sensitization at birth. J Allergy Clin Immunol 122 (2008) 407-412
162. Gorgievska-Sukarovska B., and Lipozenčić J. Obesity and allergic diseases. Acta Dermatovenereol Croat 16 (2008) 231-235
163. ISAAC SC. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC (The Internation Study of Asthma and Allergies in Childhood). Lancet 351 (1998) 1225-1232
164. Wang H., and Diepgen T.L. Atopic dermatitis and cancer risk. Br J Dermatol 154 (2006) 205-210
165. Petridou E.T., Chavelas C., Dikalioti S.K., Dessypris N., Terzidis A., Nikoulis D.I., et al. Breast cancer risk in relation to most prevalent IgE specific antibodies: a case control study in Greece. Anticancer Res 27 (2007) 1709-1713
166. Vojtechova P., and Martin R.M. The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis. Cancer Causes Control (2009) [epub ahead of print]
167. Kumar R. Prenatal factors and the development of asthma. Curr Opin Pediatr 20 (2008) 682-687
168. Amaducci L., and Tesco G. Aging as a major risk for degenerative diseases of the central nervous system. Curr Opin Neurol 7 (1994) 283-286
169. Puglielli L. Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?. Neurobiol Aging 29 (2008) 795-811
170. Whitmer R.A., Gusstafson D.R., Barrett-Connor E., Haan M.N., Gunderson E.P., and Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 71 (2008) 1057-1064
171. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia. Arch Neurol 66 (2009) 300-305
172. Craft S., and Watson G.S. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3 (2004) 169-178
173. Zhao W.Q., and Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochim Biophys Acta 1792 (2009) 482-496
174. Kulstad J.J., Green P.S., Cook D.G., Watson G.S., Reger M.A., Baker L.D., et al. Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease. Neurology 66 (2006) 1506-1510
175. Qiu W.Q., Ye Z., Kholodenko D., Seubert P., and Selkoe D.L. Degradation of amyloid beta protein by a metalloprotease secreted by microglia and other neural and nonneural cells. J Biol Chem 272 (1997) 6641-6646
176. Melnik B.C. Milk - the promoter of chronic Western diseases. Med Hypotheses 72 (2009) 631-639
177. Danby F. Diet and acne. Clin Dermatol 26 (2008) 93-96
178. Smith R.N., Mann N.J., Braue A., Mäkeläinen H., and Varigos G.A. The effect of a high protein, low glycemic load diet versus a conventional, high glycemic load diet on biochemical parameters associated with acne vulgaris. J Am Acad Dermatol 57 (2007) 247-256
179. Smith R., Mann N., Mäkeläinen H., Roper J., Braue A., and Varigos G. A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial. Mol Nutr Food Res 52 (2008) 718-726
180. Wang S., DeGroff V., and Clinton S.L. Tomato and soy polyphenols reduce insulin like growth factor-1-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. J Nutr 133 (2003) 2367-2376
181. Shankar S., Ganapathy S., and Srivastava R.K. Green tea polyphenols: biology and therapeutic implications in cancer. Front. Biosci. 12 (2007) 4881-4899
182. Li M., He Z., Ermakova S., Zheng D., Tang F., Cho Y.Y., et al. Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocathechin-3-gallate regulates cell transformation. Cancer Epidemiol Biomarkers Prev 16 (2007) 598-605
183. Cao H., Hininger-Favier I., Kelly M.A., Benaraba R., Dawson H.D., Coves S., et al. Green tea polyphenol extract regulates the expression of genes in glucose uptake and insulin signaling in rat fed a high fructose diet. J Agric Food Chem 55 (2007) 6372-6378
184. Wu L.Y., Juan C.C., Hwang L.S., Hsu Y.P., Ho P.H., and Ho L.T. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr 43 (2004) 116-124
185. Riedemann J., and Macauly V.M. IGFR1 signalling and its inhibition. Endocr Rel Cancer 13 Supp 1 (2006) S33-S43
186. Pollak M.N. Insulin-like growth factors and neoplasia. Novartis Found Symp 262 (2004) 84-98
187. Manrique C., Lastra G., Palmer J., Gardner M., and Sowers J.R. Aspirin and diabetes mellitus: revisiting an old player. Ther Adv Cardiovas Dis 2 (2008) 37-42
188. Irwin M.L., Varma K., Alvarez-Reeves M., Cadmus L., Wiley A., Chung G.G., et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship Study. Cancer Epidemiol Biomarkers Prev 18 (2009) 306-313
189. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanisms of metformin action. J Clin Invest 108 (2001) 1167-1174
190. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Delpinho R.A., et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310 (2005) 1642-1646
191. Towler M.C., and Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100 (2007) 328-341
192. Misra P. AMP activated protein kinase: a next generation target for total metabolic control. Exp Opin Ther Targets 12 (2008) 91-100
193. Zakikhani M., Dowling R., Fantus I.G., Sonenberg N., and Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 66 (2006) 10269-10273
194. Gotlieb W.H., Saumet J., Beauchamp M.C., Gu J., Lau S., Pollak M.N., et al. In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol 110 (2008) 246-250